For patients with extremely rare diseases, repurposing existing drugs may be their only hope.
Author: Karen Weintraub, USA TODAY
A year after first COVID-19 vaccine, here’s what’s next for researchers – and what worries them
On the one year anniversary of the first COVID vaccines being given, what do researchers have their sights set on? Perhaps, a future without shots.
‘Our best defense’: Pfizer says third dose of its COVID vaccine protects against omicron
A third dose of the Pfizer-BioNTech vaccine appears to be as effective against omicron as two doses were against the original variant.
COVID-19 booster doses could be authorized by Friday, ‘should be a priority’ for US adults, experts say
The CDC said it’s safe to mix vaccine brands, and data suggests Pfizer-BioNTech or Moderna would be more protective than a second J&J shot.
Pfizer antiviral drug could nearly end deaths from COVID-19, company study suggests
When given within 5 days of the onset of symptoms, Pfizer’s antiviral therapy, Paxlovid, prevented nearly 90% of deaths from COVID, a new study finds.
Parents of children 5-11 will soon face a decision on COVID vaccination: What we know, and don’t know
The Pfizer-BioNTech COVID vaccine could become available for children ages 5 to 11 as soon as next week. Here’s what we know, and don’t know.
Pig kidneys to the rescue? Groundbreaking transplant a step toward solving organ shortage
More than 100,000 Americans are waiting for an organ replacement. A breakthrough surgery offers hope
animals may help fill the void.
Will the US face another bad COVID winter? Cases are falling, but the virus isn’t done with us, experts say
COVID-19 cases are falling again in the US. Whether they will rise again depends on how Americans behave and what the unpredictable virus does next.
Woman’s depression cured by targeted electrical brain stimulation, a first, pioneered by UCSF researchers
UCSF researchers find success in first-ever treatment for severe depression targeting specific brain circuits with intermittent electrical stimulation
White House push for COVID vaccine booster shots may be premature, experts warn
The Biden administration pledged COVID vaccine boosters will be available Sept. 20, but some experts warn officials are getting ahead of the science.